Sarepta Therapeutics (SRPT) Surges After Hours

September 13, 2016 5:25 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Sarepta Therapeutics (NASDAQ: SRPT) gaining on chatter Ron Farkas is no longer at the FDA. Shares are up 10%.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Momentum Movers, Rumors, Trader Talk

Add Your Comment